The Anti-CD38 (Daratumumab Biosimilar) Monoclonal Antibody (HDBS0004) is a cutting-edge research tool designed for studying the CD38 protein, a key target in cancer therapy. This antibody, developed as a biosimilar to the monoclonal antibody daratumumab, is highly specific and binds with high affinity to CD38 on human samples. It is validated for use in various applications, including flow cytometry, immunohistochemistry, and ELISA.CD38 is a cell surface protein that plays a crucial role in the regulation of immune responses and is overexpressed in multiple myeloma and other cancers. Targeting CD38 with therapeutic antibodies like daratumumab has shown great promise in treating these malignancies.
This biosimilar antibody provides researchers with a powerful tool for studying the mechanism of action of CD38-targeted therapies and developing new strategies for cancer treatment.With its high specificity and sensitivity, the Anti-CD38 (Daratumumab Biosimilar) Monoclonal Antibody (HDBS0004) is an essential tool for researchers in the fields of oncology, immunology, and drug development. Its ability to bind specifically to CD38 makes it a valuable resource for studying the biology of this important protein and advancing our understanding of cancer immunotherapy.
Product Name:
Daratumumab (Anti-CD38) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0004
Target:
CD38
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
HuMax-CD38
Description:
Anti-CD38 (daratumumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
